StockData
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp. (TNXP) stock

TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.82−0.12 (-4.08%)

Close on Nov 18, 2026Market cap $48.37MP/E –Yield –

Tonix Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Tonix Pharmaceuticals's market cap was $64.99M on Nov 11, 2026, against $162.39M a year earlier. Over the last 5 years it ranged from $1.43M to $29.34B, with a median of $203.19M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$64.99M-59.1%
2025Dec 31, 2025$158.83M+209.4%
2024Dec 31, 2024$51.33M-77.6%
2023Dec 29, 2023$229.06M-94.5%
2022Dec 30, 2022$4.16B-85.8%
2021Dec 31, 2021$29.34B+52.6%
2020Dec 31, 2020$19.22B+5034.0%
2019Dec 31, 2019$374.40M-92.0%
2018Dec 31, 2018$4.69B-91.2%
2017Dec 29, 2017$53.21B+90.2%
2016Dec 30, 2016$27.98B-90.5%
2015Dec 31, 2015$294.53B+131.8%
2014Dec 31, 2014$127.08B+28.4%
2013Dec 31, 2013$98.98B+181.2%
2012Dec 31, 2012$35.20B–

More Tonix Pharmaceuticals figures

See a number that looks wrong?